Respiratory Rehabilitation
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
12 Nov, 2021 | 10:32h | UTCRelated:
Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
ERS Guidelines: High-flow nasal cannula in acute respiratory failure.
12 Nov, 2021 | 10:29h | UTC
2022 ASA Guidelines for Management of the Difficult Airway.
12 Nov, 2021 | 10:31h | UTCRelated:
Consensus Guideline: Pediatric Airway Management in COVID-19 Patients
Guidelines for Awake Tracheal Intubation in Adults
Position Paper: Management of Unanticipated Difficult Airways in Children in Anesthetic Practice
Review: Difficult Airway Management Algorithms (several resources on the subject)
The Difficult Airway Trolley: A Narrative Review and Practical Guide
[Preprint] RCT: In hypoxic but not critically ill patients with COVID-19, an intervention to increase prone positioning did not improve outcomes.
10 Nov, 2021 | 07:20h | UTCRCT: Prone positioning of patients with moderate hypoxia due to COVID-19 – medRxiv
Related:
RCT: Awake prone positioning reduces the need for intubation in patients with COVID-19.
Commentary from the author on Twitter (thread – click for more)
The results from the COVID-PRONE pragmatic RCT are available @medRxiv! This was a massive team effort with my co-PIs @AmolAVerma, @drfahadrazak. Our goal was to evaluate the effectiveness of prone positioning for pts hospitalized with COVID19. https://t.co/6SpjdPvT2U 🧵 1/5 pic.twitter.com/WH10ciBn4w
— Michael Fralick (@FralickMike) November 8, 2021
Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.
29 Oct, 2021 | 10:20h | UTCRelated:
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts.
28 Oct, 2021 | 10:11h | UTCCommentaries:
Respiratory Subphenotypes of COVID-19-Related ARDS – ICU Management & Practice
Commentary on Twitter
NEW—At baseline, #COVID19-related #ARDS has no consistent resp subphenotype. Pts diverged from fairly homogenous to a more heterogeneous popn, w/ trajectories of ventilatory ratio and mechanical power being the most discriminatory.
PRoVENT–COVID study: https://t.co/v8GTVcYLxq pic.twitter.com/Tv72jOzuAC
— The Lancet Respiratory Medicine (@LancetRespirMed) October 13, 2021
COVID-19 pneumonia: pathophysiology and management.
21 Oct, 2021 | 10:12h | UTCCOVID-19 pneumonia: pathophysiology and management – European Respiratory Review
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
14 Oct, 2021 | 10:15h | UTCCommentaries:
Most COVID-19 survivors have symptoms 6 months on, review finds – CIDRAP
How many people get ‘long COVID’? More than half, researchers find – Penn State
Related:
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Commentary on Twitter
Most #COVID19 survivors have symptoms 6 months on, review finds
Data on more than 250,000 survivors reveal 54% had at least 1 symptom 6 months or more after diagnosis #LongCovidhttps://t.co/xd0lvhQFfL pic.twitter.com/65mqe7SQPg
— CIDRAP (@CIDRAP) October 13, 2021
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
8 Oct, 2021 | 10:45h | UTCRelated:
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Commentary on Twitter (thread – click for more)
🆕 WHO clinical case definition for post #COVID19 condition, also called 'long COVID' https://t.co/WoiLcwsgJX pic.twitter.com/Z0olrHlWPC
— World Health Organization (WHO) (@WHO) October 7, 2021
Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom.
30 Sep, 2021 | 10:25h | UTCNews release: Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom – University of Oxford
Commentaries:
Two studies tie long COVID-19 to severe initial illness – CIDRAP
Covid: 37% of people have symptoms six months after infection – The Guardian
Long Covid is a bigger problem than we thought – CNN
Supplement: Acute Respiratory Distress Syndrome.
30 Sep, 2021 | 10:03h | UTCHomepage: Acute Respiratory Distress Syndrome – Critical Care Clinics
The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019
Toward Optimal Acute Respiratory Distress Syndrome Outcomes
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury
COVID-19–Associated Acute Respiratory Distress Syndrome
Pathophysiology of the Acute Respiratory Distress Syndrome
Acute Kidney Injury and Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Fluid Therapy and Acute Respiratory Distress Syndrome
Pharmacologic Treatments for Acute Respiratory Distress Syndrome
Long-Term Outcomes in Acute Respiratory Distress Syndrome
Related:
Position paper: Advancing precision medicine for acute respiratory distress syndrome.
Review: Personalized mechanical ventilation in acute respiratory distress syndrome.
Seminar | Acute respiratory distress syndrome.
ARDS: Contemporary management and novel approaches during COVID-19
Characterizing long COVID: a living systematic review.
29 Sep, 2021 | 10:29h | UTCCharacterising long COVID: a living systematic review – BMJ Global Health
Related:
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Commentary on Twitter
https://twitter.com/CharitiniSt/status/1442528255718748164
Systematic Review: Pulmonary rehabilitation for interstitial lung disease.
26 Sep, 2021 | 21:31h | UTCPulmonary rehabilitation for interstitial lung disease – Cochrane Library
Summary: Pulmonary rehabilitation for interstitial lung disease – Cochrane Library
Long Covid – The illness narratives.
22 Sep, 2021 | 10:19h | UTCLong Covid – The illness narratives – Social Science & Medicine
Commentary on Twitter
https://twitter.com/trishgreenhalgh/status/1439199576158883843
The use of head helmets to deliver noninvasive ventilatory support: a comprehensive review of technical aspects and clinical findings.
17 Sep, 2021 | 09:57h | UTC
Ten strategies to optimize early mobilization and rehabilitation in intensive care.
10 Sep, 2021 | 05:14h | UTCTen strategies to optimize early mobilization and rehabilitation in intensive care – Critical Care
Isn’t it time to abandon ARDS? The COVID-19 lesson.
7 Sep, 2021 | 21:34h | UTCIsn’t it time to abandon ARDS? The COVID-19 lesson – Critical Care
Commentary on Twitter
#CritCare #OA #Gattinoni & #Marini: Keeping or abandoning #ARDS?
▶️ pros
▶️ conshttps://t.co/tIhusXT2S7#FOAMed #FOAMcc #BMC #COVID19 #Rx #RCT #PEEP #respiratory_failure #Personalized pic.twitter.com/M6aoiSAn3m— Critical Care (@Crit_Care) September 7, 2021
Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.
2 Sep, 2021 | 10:10h | UTCCommentaries:
Long Covid in children ‘nowhere near scale feared’ – BBC
Related:
Cohort study: Risk factors for long covid in previously hospitalized children.
M-A: More than 50 long-term effects of COVID-19.
Commentary on Twitter (thread – click for more)
The worlds biggest study of post acute #COVID19 symptoms in children is out as a pre-print – the CLoCK study!
Fortunately results are very reassuring regarding symptom frequency and impact
Some important lessons, let's take a look 🧵
— Alasdair Munro (@apsmunro) September 1, 2021
RCT: Among critically ill patients, targeting oxygenation to a low-normal range vs. high-normal range did not result in a reduction in organ dysfunction.
2 Sep, 2021 | 08:23h | UTCEffect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients: A Randomized Clinical Trial – JAMA (free for a limited period)
Related:
M-A of randomized trials: Conservative oxygen therapy for critically ill patients.
Oxygen administration for patients with ARDS – Journal of Intensive Care
Commentary on Twitter
Multicenter RCT found, among critically ill patients, targeting oxygenation to a low-normal range compared with a high-normal range did not result in a statistically significant reduction in organ dysfunction https://t.co/lEq28bqmM4 #ISICEM21
— JAMA (@JAMA_current) August 31, 2021
RCT: In patients with acute hypoxemic respiratory failure, a strategy of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal was not associated with improved outcomes.
2 Sep, 2021 | 08:21h | UTCEffect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial – JAMA (free for a limited period)
Related: Randomized Trial: Low vs Intermediate Tidal Volume Strategy in ICU Patients Without ARDS
Commentary on Twitter
In this randomized clinical trial that included 412 adults, 90-day mortality was 41.5% in the extracorporeal carbon dioxide removal group and 39.5% in the standard care group, a difference that was not statistically significant https://t.co/jhCY2r4qjX #ISICEM21
— JAMA (@JAMA_current) August 31, 2021
Cohort study: Most COVID-19 hospital survivors had a good physical and functional recovery after 1 year of follow-up, but around half of the patients had at least one sequelae symptom.
27 Aug, 2021 | 10:13h | UTC1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study – The Lancet
Editorial: Understanding long COVID: a modern medical challenge – The Lancet
Related:
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
New guidelines to help doctors manage long COVID patients published.
M-A: Physical rehabilitation in the ICU improves physical function and reduces ICU and hospital length of stay.
27 Aug, 2021 | 09:02h | UTCPhysical Rehabilitation in the ICU: A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)
WHO Guide | Support for rehabilitation: self-management after COVID-19-related illness.
26 Aug, 2021 | 09:21h | UTC
Commentary on Twitter
The World Health Organisation have just published: Support for rehabilitation: self-management after COVID-19-related illness, 2nd ed. Written by the Leeds Rehabilitation team. Accessed from https://t.co/Ep4KG2FTiQ Will be in all European languages soon.
— Derick Wade (@derickwaderehab) August 25, 2021
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.
26 Aug, 2021 | 08:59h | UTCInvited commentary: Charting a course for the management of long COVID
Related: M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Commentary on Twitter
NEW Position Paper—The long-term sequelae of #COVID19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
From the International COVID-19 Airways Diseases Group https://t.co/QAoUhzbYtb pic.twitter.com/jj4rxEGyzC
— The Lancet Respiratory Medicine (@LancetRespirMed) August 18, 2021
New guidelines to help doctors manage long COVID patients published.
26 Aug, 2021 | 09:01h | UTCNew guidelines to help doctors manage long COVID patients published – Imperial College London
Original article: Recommendations for the recognition, diagnosis, and management of long covid: A Delphi study – British Journal of General Practice
Related: M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)